The Cost-Effectiveness of Treating All Patients with Type 2 Diabetes with Angiotensin-Converting Enzyme Inhibitors

Figure 2. For comparison, the expected outcome for patients who do not receive angiotensin-converting enzyme inhibitors is also shown.
Figure 2. For comparison, the expected outcome for patients who do not receive angiotensin-converting enzyme inhibitors is also shown. Distribution of health states after 10 years for each of the three strategies.

This Article

  1. Ann Intern Med November 2, 1999 vol. 131 no. 9 660-667
  1. AbstractFREE
  2. Figures
  3. Full Text
  4. Full Text (PDF)

Current Issue

  1. November 17, 2009, 151 (10)
  1. Alert me to current issues